Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Epizyme, Inc. (EPZM)

« Back to company index

EPZM Chatter Timeline

Stock Ticker for EPZM

Most Active Tweeters for EPZM

UserTweets
@Tickeron 13
@CaesarBiotech 4
@dailypoliticaln 3
@EnterpriseLeade 3
@TickerReport 3

Recent Tweets for EPZM

Tickeron @Tickeron
$EPZM's 10-day Moving Average crossed above its 50-day Moving Average on October 16, 2020. View odds for this and o… https://t.co/XBOj9HBco6
October 25th 2020, 6:10pm
Tickeron @Tickeron
$EPZM's 10-day Moving Average crossed above its 50-day Moving Average on October 16, 2020. View odds for this and o… https://t.co/HfwoHV3BIl
October 24th 2020, 7:10pm
Tickeron @Tickeron
$EPZM enters an Uptrend as Momentum Indicator exceeded the 0 level on October 7, 2020. View odds for this and other… https://t.co/Ip3vNwyDdC
October 23rd 2020, 9:10pm
Tickeron @Tickeron
$EPZM enters an Uptrend as Momentum Indicator exceeded the 0 level on October 7, 2020. View odds for this and other… https://t.co/XsK6g6DWYw
October 22nd 2020, 7:10pm
Tickeron @Tickeron
$EPZM enters an Uptrend as Momentum Indicator exceeded the 0 level on October 7, 2020. View odds for this and other… https://t.co/xz20AMJQ07
October 21st 2020, 8:10pm
ZolmaxNews @ZolmaxNews
Epizyme Sees Unusually High Options Volume $EPZM https://t.co/iBHlOJxr75
October 21st 2020, 6:10am
AmericanBanking @AmericanBanking
Epizyme Target of Unusually High Options Trading $EPZM https://t.co/Cq05H0rdSC #stocks
October 21st 2020, 5:10am
ZolmaxNews @ZolmaxNews
Epizyme Target of Unusually High Options Trading $EPZM https://t.co/yVW9X6deVB
October 21st 2020, 5:10am
dakotafinancial @dakotafinancial
Epizyme Target of Unusually High Options Trading $EPZM https://t.co/BIpTphYxBy
October 21st 2020, 5:10am
Tickeron @Tickeron
$EPZM's price moved above its 50-day Moving Average on October 14, 2020. View odds for this and other indicators:… https://t.co/zHgIzJS5LY
October 20th 2020, 6:10pm
OlympiaReport @OlympiaReport
Brokerages Expect Epizyme, Inc. $EPZM Will Post Earnings of -$0.60 Per Share https://t.co/RQNY9quI6C
October 20th 2020, 4:10pm
OlympiaReport @OlympiaReport
Zacks: Brokerages Anticipate Epizyme, Inc. $EPZM Will Post Quarterly Sales of $7.72 Million https://t.co/0TQRPHA0ur
October 20th 2020, 4:10pm
WeekHerald @WeekHerald
Zacks: Analysts Expect Epizyme, Inc. $EPZM Will Announce Earnings of -$0.60 Per Share https://t.co/24LNSdIGXU
October 20th 2020, 4:10pm
CaesarBiotech @CaesarBiotech
$EPZM Tazemetostat Monotherapy Generates Durable Responses in Heavily Pretreated Follicular Lymphoma 1/2… https://t.co/sI9ZNIuVQq
October 20th 2020, 1:10pm
CaesarBiotech @CaesarBiotech
$EPZM “Furthermore, the objective response rate for patients with double-refractory disease was high, suggesting th… https://t.co/gy6a3e4SGa
October 20th 2020, 1:10pm
TranscriptDaily @TranscriptDaily
Epizyme, Inc. $EPZM Receives $27.00 Consensus PT from Analysts https://t.co/58sgMzadfc
October 20th 2020, 11:10am
EnterpriseLeade @EnterpriseLeade
Epizyme $EPZM Upgraded to Hold at BidaskClub https://t.co/SW8ORd2YxT
October 20th 2020, 2:10am
EnterpriseLeade @EnterpriseLeade
Epizyme $EPZM Rating Increased to Hold at BidaskClub https://t.co/XIbmB7FEp9
October 20th 2020, 2:10am
TranscriptDaily @TranscriptDaily
Epizyme $EPZM Lifted to Hold at BidaskClub https://t.co/UDoDCUO7kW
October 20th 2020, 2:10am
ThisLincolnian @ThisLincolnian
Epizyme Sees Unusually High Options Volume $EPZM https://t.co/T3WghqnVJ0
October 20th 2020, 1:10am
dailypoliticaln @dailypoliticaln
Epizyme Sees Unusually High Options Volume $EPZM https://t.co/ZFewBifpCg
October 20th 2020, 1:10am
WatchlistN @WatchlistN
Epizyme Sees Unusually High Options Volume $EPZM https://t.co/waugbrvCng
October 20th 2020, 1:10am
TickerReport @TickerReport
Epizyme Sees Unusually High Options Volume $EPZM https://t.co/P4K3N2uSgX
October 20th 2020, 1:10am
Tickeron @Tickeron
$EPZM's 10-day Moving Average moved above its 50-day Moving Average on October 16, 2020. View odds for this and oth… https://t.co/HViq9vJH9L
October 19th 2020, 6:10pm
WeekHerald @WeekHerald
Epizyme Sees Unusually High Options Volume $EPZM https://t.co/aLko04rgrt
October 19th 2020, 4:10pm
AmericanBanking @AmericanBanking
Epizyme Sees Unusually High Options Volume $EPZM https://t.co/aO0oKWfSRT #stocks
October 19th 2020, 4:10pm
CaesarBiotech @CaesarBiotech
$EPZM Epizyme Announces Two Lancet Oncology Publications on TAZVERIK® (tazemetostat) Phase 2 Data in Epithelioid Sa… https://t.co/SMNpi96T5A
October 19th 2020, 1:10pm
BACScoreChanges @BACScoreChanges
#Epizyme $EPZM BidaskScore is Upgraded to Held https://t.co/xpAt4PEtc9
October 19th 2020, 9:10am
dispatchtribune @dispatchtribune
Epizyme $EPZM Lifted to Hold at BidaskClub https://t.co/uDWOqv03qW
October 19th 2020, 2:10am
stocknewstimes @stocknewstimes
Epizyme $EPZM Rating Increased to Hold at BidaskClub https://t.co/WcaKLP4D90
October 19th 2020, 2:10am
Tickeron @Tickeron
$EPZM's 10-day Moving Average broke above its 50-day Moving Average on October 16, 2020. View odds for this and oth… https://t.co/EbVbmCAovi
October 18th 2020, 6:10pm
EnterpriseLeade @EnterpriseLeade
-$0.60 Earnings Per Share Expected for Epizyme Inc $EPZM This Quarter https://t.co/esKotWMcYr
October 18th 2020, 11:10am
stocknewstimes @stocknewstimes
Epizyme Inc $EPZM Expected to Post Quarterly Sales of $7.72 Million https://t.co/Z1SZEZ5JJI
October 18th 2020, 9:10am
TheMarketsDaily @TheMarketsDaily
Epizyme $EPZM Upgraded by BidaskClub to Hold https://t.co/3WrJcKFtYN
October 18th 2020, 7:10am
ZolmaxNews @ZolmaxNews
Epizyme $EPZM Upgraded by BidaskClub to Hold https://t.co/DUS52GXhVl
October 18th 2020, 6:10am
Tickeron @Tickeron
$EPZM's 10-day Moving Average broke above its 50-day Moving Average on October 16, 2020. View odds for this and oth… https://t.co/m40OaUHpaV
October 17th 2020, 7:10pm
Tickeron @Tickeron
$EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/yf67ympdgm
October 16th 2020, 8:10pm
ResearchPool @ResearchPool
$EPZM #Epizyme Inc ... Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 9: [...]… https://t.co/h5zfWexaPp
October 16th 2020, 10:10am
TickerReport @TickerReport
Brokerages Anticipate Epizyme Inc $EPZM Will Post Earnings of -$0.60 Per Share https://t.co/GtX2KgMFZs
October 16th 2020, 8:10am
dailypoliticaln @dailypoliticaln
Epizyme Inc $EPZM Expected to Announce Earnings of -$0.60 Per Share https://t.co/GmFxxWWsRX
October 16th 2020, 7:10am
PMDiChristina @PMDiChristina
Been waiting for this name to show a little more strength before posting charts. $EPZM I like what I see. https://t.co/RiY9mcIN1X
October 15th 2020, 8:10pm
Tickeron @Tickeron
$EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/dsmMxnTYhf
October 15th 2020, 7:10pm
TickerReport @TickerReport
Epizyme Inc $EPZM Expected to Post Quarterly Sales of $7.72 Million https://t.co/Ehq6y6fVzH
October 15th 2020, 1:10am
dailypoliticaln @dailypoliticaln
Zacks: Analysts Anticipate Epizyme Inc $EPZM Will Post Quarterly Sales of $7.72 Million https://t.co/VKGAB29u6t
October 15th 2020, 1:10am
WatchlistN @WatchlistN
Epizyme Inc $EPZM Expected to Post Quarterly Sales of $7.72 Million https://t.co/QwwHLOit5P
October 15th 2020, 1:10am
Tickeron @Tickeron
$EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/zcGBXkqvEs
October 14th 2020, 8:10pm
Tickeron @Tickeron
$EPZM in -1.27% Downtrend, sliding for three consecutive days on October 9, 2020. View odds for this and other indi… https://t.co/GxVvqZvGV9
October 13th 2020, 8:10pm
CaesarBiotech @CaesarBiotech
@_B_I_O_T_E_C_H_ $EPZM Tazverik is a valuable drug which will likely transform NHL soc (all lines). The most intri… https://t.co/aFuhwDLN9A
October 13th 2020, 4:10am
dakotafinancial @dakotafinancial
Epizyme $EPZM Lifted to Sell at BidaskClub https://t.co/SBubcOkf6O
October 11th 2020, 11:10pm
bbnsnews @bbnsnews
Epizyme $EPZM Lifted to Sell at BidaskClub https://t.co/GtUAFUFZB1
October 11th 2020, 11:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.